Vacuolar myelopathy: a case report of functional, clinical, and radiological improvement after highly active antiretroviral therapy

International Journal of Infectious Diseases

Volumn 12, Issue 4, 2008, Pages 442-444

  Bizaare, Maresce ^a   Dawood, Halima ^a   Moodley, Anand ^a  

^a GREY'S HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BACKACHE; CASE REPORT; CD4 LYMPHOCYTE COUNT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LETTER; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; SPINAL CORD DISEASE; VIRUS LOAD; WEAKNESS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MALE; SPINAL CORD COMPRESSION; THORACIC VERTEBRAE;

EID: 44649167568     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.09.014     Document Type: Letter

References (10)

1. Di Rocca A. HIV associated myelopathy. Curr Treat Options Infect Dis 5 (2003) 457-465
2. Petito C.K., Navia B.A., Cho E.S., Jordan B.D., George D.C., and Price R.W. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 312 (1985) 874-879
3. Dal Pan G.J., Glass J.D., and McArthur J.C. Clinicopathologic correlations of HIV associated vacuolar myelopathy: an autopsy based case-control study. Neurology 44 (1994) 2159-2164
4. Fernandez-Fernandez F.J., de la Fuente-Aguado J., Ocampo-Hermida A., and Iglesias-Castanon A. Remission of HIV-associated myelopathy after highly active antiretroviral therapy. J Postgrad Med 50 (2004) 195-196
5. McArthur J.C., Brew B., and Nath A. Neurological complications of HIV Infection. Lancet Neurol 4 (2005) 543-555
6. Singh NN, Thomas FP. HIV-1 associated vacuolar myelopathy. eMedicine-WebMD. March 2007. Available at: http://www.emedicine.com/NEURO/topic449.htm (accessed November 2007).
7. Hepburn M.J., Dyal K., Runser L.A., Barfield R.L., Hepburn L.M., and Fraser S.L. Low serum vitamin B12 levels in an outpatient HIV-infected population. Int J STD AIDS 15 (2004) 127-133
8. Remacha A.F., Codafalch J., Sarda P., Barcelo M., and Fuster M. Vitamin B12 metabolism in HIV-infected patients in the age of highly active antiretroviral therapy: role of homocysteine in assessing vitamin B12 stores. Am J Clin Nutr 77 (2003) 420-424
9. Swagel E. The elusive (and maybe non-existent) connection between vitamin B12 and HIV. Nutrition Bytes 1996; 2:Article 4. Available at: http://repositories.cdlib.org/uclabiolchem/nutritionbytes/vol2/iss2/art4 (accessed November 2007).
10. Nagaishi A., Takashima H., Fukuda Y., and Kuroda Y. [A case of subacute combined degeneration with normal serum vitamin B12 level] (in Japanese). Rinsho Shinkeigaku 43 (2003) 552-555